[go: up one dir, main page]

MC1709A1 - Derives de cholecalciferol - Google Patents

Derives de cholecalciferol

Info

Publication number
MC1709A1
MC1709A1 MC851803A MC1803A MC1709A1 MC 1709 A1 MC1709 A1 MC 1709A1 MC 851803 A MC851803 A MC 851803A MC 1803 A MC1803 A MC 1803A MC 1709 A1 MC1709 A1 MC 1709A1
Authority
MC
Monaco
Prior art keywords
methyl
octahydro
indene
trifluoromethyl
hexenyl
Prior art date
Application number
MC851803A
Other languages
English (en)
French (fr)
Inventor
Enrico Baggiolini
Giacomo Pizzolato
Milan Uskokovic
Gary Truitt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1709A1 publication Critical patent/MC1709A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C7/00Purification; Separation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/743Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups having unsaturation outside the rings, e.g. humulones, lupulones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/44Halogenated unsaturated alcohols containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C07C45/305Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Analytical Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Water Supply & Treatment (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MC851803A 1984-11-16 1985-11-14 Derives de cholecalciferol MC1709A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/672,059 US4613594A (en) 1984-11-16 1984-11-16 Fluorinated vitamin D3 compounds

Publications (1)

Publication Number Publication Date
MC1709A1 true MC1709A1 (fr) 1986-09-22

Family

ID=24696990

Family Applications (1)

Application Number Title Priority Date Filing Date
MC851803A MC1709A1 (fr) 1984-11-16 1985-11-14 Derives de cholecalciferol

Country Status (21)

Country Link
US (1) US4613594A (pt)
EP (1) EP0182298B1 (pt)
JP (1) JPS61122237A (pt)
KR (1) KR930007993B1 (pt)
AR (1) AR242767A1 (pt)
AT (1) ATE48412T1 (pt)
AU (1) AU588012B2 (pt)
CA (1) CA1286693C (pt)
DE (1) DE3574587D1 (pt)
DK (1) DK159652C (pt)
ES (1) ES8801198A1 (pt)
FI (1) FI84599C (pt)
HU (1) HU194162B (pt)
IE (1) IE58851B1 (pt)
IL (1) IL77052A (pt)
MC (1) MC1709A1 (pt)
NO (1) NO162906C (pt)
NZ (1) NZ214175A (pt)
PH (1) PH21540A (pt)
PT (1) PT81502B (pt)
ZA (1) ZA858151B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63196556A (ja) * 1987-02-10 1988-08-15 Taisho Pharmaceut Co Ltd 含フツ素ビタミンd誘導体
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
WO1990009179A1 (en) * 1989-02-16 1990-08-23 University Of Georgia Research Foundation, Inc. Treatment of tibial dyschondroplasia
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンd▲下3▼類固型製剤
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5278155A (en) * 1991-06-05 1994-01-11 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and cell differentiation-inducing agent containing the same
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
ATE143007T1 (de) * 1991-07-05 1996-10-15 Duphar Int Res Vitamin-d derivat, verfahren zu dessen herstellung sowie zwischenprodukte dafür
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
US5753638A (en) * 1992-10-07 1998-05-19 Hoffmann-La Roche Inc. Method of treating hyperproliferative skin disease with Vitamin D3 fluorinated analogs
US5547947A (en) * 1993-03-11 1996-08-20 Hoffmann-La Roche Inc. Methods of treatment
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
JP2008519808A (ja) 2004-11-12 2008-06-12 ビオエクセル エスピーエー 膀胱癌治療のためのビタミンd誘導体及び抗増殖薬の併用
CN117088798A (zh) * 2023-09-04 2023-11-21 正大制药(青岛)有限公司 一种氟骨化醇22,23-双键杂质的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248791A (en) * 1980-02-04 1981-02-03 Wisconsin Alumni Research Foundation 25-Hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
JPS57149224A (en) * 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
US4358406A (en) * 1981-07-27 1982-11-09 Wisconsin Alumni Research Foundation 26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
ATE34977T1 (de) * 1983-01-28 1988-06-15 Hoffmann La Roche Verfahren zur herstellung von cholecalciferolderivaten.
US4508651A (en) * 1983-03-21 1985-04-02 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxyergocalciferol
US4505906A (en) * 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US4521410A (en) * 1984-05-03 1985-06-04 The General Hospital Corporation Vitamin D glycosyl orthoesters

Also Published As

Publication number Publication date
DE3574587D1 (de) 1990-01-11
PT81502A (en) 1985-12-01
KR860004073A (ko) 1986-06-16
NO162906B (no) 1989-11-27
AR242767A1 (es) 1993-05-31
US4613594A (en) 1986-09-23
HU194162B (en) 1988-01-28
EP0182298B1 (de) 1989-12-06
FI84599C (fi) 1991-12-27
IL77052A0 (en) 1986-04-29
ES8801198A1 (es) 1987-12-16
AU5089885A (en) 1986-05-29
PT81502B (pt) 1988-03-03
NO854576L (no) 1986-05-20
NZ214175A (en) 1989-04-26
EP0182298A1 (de) 1986-05-28
HUT39138A (en) 1986-08-28
FI854492L (fi) 1986-05-17
IL77052A (en) 1990-02-09
FI84599B (fi) 1991-09-13
FI854492A0 (fi) 1985-11-14
IE852875L (en) 1986-05-16
DK159652C (da) 1991-04-08
AU588012B2 (en) 1989-09-07
JPS61122237A (ja) 1986-06-10
NO162906C (no) 1990-03-07
IE58851B1 (en) 1993-11-17
DK524585A (da) 1986-05-17
ZA858151B (en) 1986-06-25
DK524585D0 (da) 1985-11-13
PH21540A (en) 1987-11-16
ES548910A0 (es) 1987-12-16
DK159652B (da) 1990-11-12
ATE48412T1 (de) 1989-12-15
CA1286693C (en) 1991-07-23
JPH051770B2 (pt) 1993-01-11
KR930007993B1 (ko) 1993-08-25

Similar Documents

Publication Publication Date Title
MC1709A1 (fr) Derives de cholecalciferol
MC1997A1 (fr) Preparation de derives de cholecalciferol
FR2634200A1 (fr) Nouveaux composes derives de la vitamine d, leur procede de preparation et compositions pharmaceutiques contenant ces composes
FR2630740A1 (fr) Composes derives de vitamine d3, procede pour les preparer et leur utilisation
EP0290321B1 (fr) Nouveaux beta-D-phényl-thioxylosides, leur procédé de préparation et leur application en thérapeutique
FR2554444A1 (fr) 1,25-dihydroxyvitamines d2 et procedes pour les preparer
FR2573760A1 (fr) Composes derives du cholecalciferol, composition pharmaceutique antitumorale et utilisation desdits composes dans la preparation de cette composition pharmaceutique
FR2565227A1 (fr) 1,24-dihydroxy-22-vitamines d3 et procede pour les preparer
MC1998A1 (fr) Composes pour le traitement des maladies hyperproliferatibes et procede de preparation
EP0315540A1 (fr) Esters rétinoiques de macrolides, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
EP0315539A2 (fr) Esters aromatiques polycycliques d'antibiotiques macrolidiques et lincosamidiques, leur procédé de préparation et compositions pharmaceutiques et cosmétiques les contenant
FR2573759A1 (fr) Composes derives du cholecalciferol et leur procede de preparation, composition pharmaceutique et utilisation desdits composes dans la preparation de cette composition
KR940003360B1 (ko) 불포화 측쇄를 갖는 1α-히드록시비타민 D동족체
EP0342115A1 (fr) Nouveaux eicosanoides sulfurés et leur application en pharmacie et en cosmétique
MC1175A1 (fr) Derives polyeniques
CA1203234A (fr) PROCEDE DE PREPARATION DE NOUVEAUX DERIVES DICHLORES DE LA SERIE 16.alpha.-METHYL PREGNANE
CA1140110A (fr) Procede de preparation de nouveaux derives de l'androst-4-ene
EP0012072B1 (fr) Bêta-lactones dérivées de l'acide 2-hydroxy cyclopentane carboxylique, procédé pour leur préparation et compositions pharmaceutiques les renfermant
PL174912B1 (pl) Nowe związki farmakologicznie czynne z grupy witamin D i sposób ich otrzymywania
MC1727A1 (fr) Derives de cholecalciferol
FR2558828A1 (fr) " 1a,25-dihydroxy-22z-deshydrovitamine d " composition pharmaceutique et procede de preparation
EP0002635A1 (fr) Procédé de préparation de dérivés de thiéno (2,3-c) et (3,2-c) pyridines, nouveaux dérivés de la thiéno (2,3-c) pyridine obtenus et leur application thérapeutique
EP0082040B1 (fr) Dérivés de diaza-3,7a cyclohepta(j,k)fluorènes, leur préparation et leur application en thérapeutique
CH676598A5 (pt)
CH670633A5 (pt)

Legal Events

Date Code Title Description
YP Annual fee paid